A 28-year-old primigravida comes to the office for an initial prenatal visit at 10 weeks gestation. The patient reports feeling well and denies any vaginal discharge, pruritus, dysuria, or pelvic pain. Her medical history is unremarkable, and she takes no medications other than a prenatal vitamin. Vital signs are within normal limits. A pelvic examination is performed, during which a small amount of thin, homogeneous, grayish fluid is noted in the vaginal vault. The cervix appears normal and closed, with no cervical motion tenderness. Point-of-care testing of the vaginal fluid reveals a pH of 5.5, and a prominent amine odor is noted upon the addition of potassium hydroxide. Microscopic evaluation of a wet mount shows numerous squamous epithelial cells with margins completely obscured by small bacteria. Which of the following is the most appropriate next step in management?
- No pharmacologic intervention is indicatedCevap
- BPrescribe a seven-day course of oral metronidazole
- CPrescribe intravaginal clindamycin therapy
- DPrescribe oral metronidazole for the patient and her sexual partner
- EPrescribe a single dose of oral azithromycin